Intellipharmaceutics out-licenses antidepressant in U.S. to Tris Pharma - Seeking Alpha

Submitted by Anonymous (not verified) on Thu, 08/15/2019 - 19:25

Intellipharmaceutics out-licenses antidepressant in U.S. to Tris Pharma  Seeking AlphaIntellipharmaceutics ([[IPCI]] +0.4%) inks an agreement with Tris Pharma granting the latter exclusive distribution rights to five strengths of antidepress.